Backgrounds/Aims Intrahepatic cholangiocarcinoma (ICC) is a highly desmoplastic tumor with poor prognosis even after curative resection. We investigated the associations between the composition of the ICC stroma and immune cell infiltration and aimed to develop a stromal-immune signature to predict prognosis in surgically treated ICC.
Methods We recruited 359 ICC patients and performed immunohistochemistry to detect α-smooth muscle actin (α-SMA), CD3, CD4, CD8, Foxp3, CD68, and CD66b. Aniline was used to stain collagen deposition. Survival analyses were performed to detect prognostic values of these markers. Recursive partitioning for a discrete-time survival tree was applied to define a stromal-immune signature with distinct prognostic value. We delineated an integrated stromal-immune signature based on immune cell subpopulations and stromal composition to distinguish subgroups with different recurrence-free survival (RFS) and overall survival (OS) time.
Results We defined four major patterns of ICC stroma composition according to the distributions of α-SMA and collagen: dormant (α-SMAlow/collagenhigh), fibrogenic (α-SMAhigh/collagenhigh), inert (α-SMAlow/collagenlow), and fibrolytic (α-SMAhigh/collagenlow). The stroma types were characterized by distinct patterns of infiltration by immune cells. We divided patients into six classes. Class I, characterized by high CD8 expression and dormant stroma, displayed the longest RFS and OS, whereas Class VI, characterized by low CD8 expression and high CD66b expression, displayed the shortest RFS and OS. The integrated stromal-immune signature was consolidated in a validation cohort.
Conclusions We developed and validated a stromal-immune signature to predict prognosis in surgically treated ICC. These findings provide new insights into the stromal-immune response to ICC.
Citations
Citations to this article as recorded by
Development and validation of a biopsy-based model using tumor-associated neutrophils to predict neoadjuvant chemotherapy response in osteosarcoma: a large single-center retrospective cohort study Wanjiang Feng, Zibo Xu, Ziming Yan, Hongyu Wu, Haoyu Guo, Yuejun Luo, Weifeng Liu Journal of Bone Oncology.2026; 58: 100764. CrossRef
Predictive Immunohistochemistry in Cholangiocarcinoma: Current Clinical Utility, Practical Limitations, and Emerging Directions Francesco Vasuri, Alessandra Boccaccino, Stefano Tamberi, Luca Saragoni APMIS.2026;[Epub] CrossRef
Cystatin B Promotes the Proliferation, Migration, and Invasion of Intrahepatic Cholangiocarcinoma Dai Zhang, Bao-Ye Sun, Jing-Fang Wu, Zhu-Tao Wang, Su-Su Zheng, Guo-Qiang Sun, Xu-Kang Gao, Jian Zhou, Jia Fan, Bo Hu, Shuang-Jian Qiu, Bo-Heng Zhang Current Oncology.2025; 32(2): 56. CrossRef
Reassessing the Prognostic Value of Lymph Node Metastasis in Deficient Mismatch Repair Colorectal Cancer Zilan Ye, Dakui Luo, Fan Chen, Jiayu Chen, Zezhi Shan, Junyong Weng, Yu Zhang, Qingguo Li, Xinxiang Li Current Oncology.2025; 32(5): 254. CrossRef
The intratumoral balance of IgG4+ plasma cells and CD8+ T cells is associated with prognosis of intrahepatic cholangiocarcinoma after curative resection Yu-Hang Ye, Hao-Yang Xin, Ning Li, Chu-Bin Luo, Long Chen, Jing-Yue Pan, Ye Xu, Fan Weng, Cun-Yang Tu, Ya-Ya Ji, Jia Fan, Jian Zhou, Zheng-Jun Zhou, Shao-Lai Zhou Digestive and Liver Disease.2025; 57(7): 1487. CrossRef
A blood test-based nomogram to predict the progression-free survival of patients with intrahepatic cholangiocarcinoma after surgical resection Lirong Peng, Yang Shi, Shuang Yang, Cunyan Li Frontiers in Oncology.2025;[Epub] CrossRef
Prognostic impact of tumor microenvironment characteristics in intrahepatic cholangiocarcinoma: A systematic review and meta-analysis Zaiba Shafik Dawood, Mujtaba Khalil, Arsalan Javid, Abdul Ali, Usama Waqar, Zayan Alidina, Illiyun Banani, Timothy M. Pawlik Surgical Oncology.2025; 63: 102307. CrossRef
A prospective study of tumor-stroma ratio in resected intrahepatic mass-forming cholangiocarcinoma: prognostic value and correlation with gadoxetic acid-enhanced MRI Yi-Jun Pan, Ling-Li Chen, Zheng Wang, Jiang Lin, Yan Shan, Peng-Ju Xu European Radiology.2025; 36(5): 3994. CrossRef
Establishing prognostic models for intrahepatic cholangiocarcinoma based on immune cells Zhuo-Ran Wang, Cun-Zhen Zhang, Zhan Ding, Yi-Zhuo Li, Jian-Hua Yin, Nan Li World Journal of Gastrointestinal Oncology.2024; 16(10): 4092. CrossRef
First
Prev
